Learn more about whether Intra-Cellular Therapies, Inc. or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ ...

Sei Investments Co. decreased its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 30.5% in the 4th quarter, ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

At Jazz Pharmaceuticals, Gaslightwala oversaw a portfolio of products with annual sales of $1B, including ZIIHERA®, ZEPZELCA®, and RYLAZE®. AKTX-101 is Akari's lead candidate targeting the ...

These brands include ZIIHERA ® for HER2+ cancers, ZEPZELCA ® for small cell lung cancer, and RYLAZE ®, DEFITELIO ®, and VYXEOS ® for a range of hematological malignancies. As previously announced, Mr.

The Business Research Company The Business Research Company's Rylaze Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Updated 2025 Market Reports Released: Trends, Fo... ...

LONDON, GREATER LONDON, UNITED KINGDOM, March 12, 2025 /EINPresswire.com/ -- How Has the Rylaze Market Performed Recently, and What Growth Is Expected? The Rylaze ...

The Business Research Company's Rylaze Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early ...